SBN 0.00% 0.0¢ sun biomedical limited

smoke and mirrors, page-5

  1. 13,477 Posts.
    lightbulb Created with Sketch. 2672
    Hi Mon,

    I can relate to your comment that:

    "I for one can't believe peoples expectations and concerns over no news. Must be bad seems the only response"

    But, in reality, not much has happened. Just a couple of things - yesterday's dump and the upset over no Medica news - makes things seem not as good as they actually are.

    I would think that most of those reasonably well informed will still be very comfortable with their investment (or as much as you can be in these dire times).

    A couple of the larger holders have decided to move on (at least for the time being) but this happens in all stocks for reasons that are nothing to do with those stocks.

    A friend of gsw's apparently sold a large part of his stake yesterday principally, I understand, because he is uncomfortable being in the market AT ALL in this macro-environment and, particularly, in illiquid stocks. But the decision taken was of course 'high risk' (with little further downside and plenty of potential upside - particularly if Mexico suddenly comes through) and had nothing to do with the unfolding of SBN's business plan.

    As well, some other holder (with the 7.0m at 1.1c) has some unknown reason for selling. But what a goose to show his hand in that way! With the macro-economy collapsing around us and frustrations over perceived lack of progress, the gambit was bound to do what it did - that is, suck sellers in below it, as particularly seen yesterday. And, of course, with such a dumb strategy, he is still sitting there high and dry.

    What else has happened?

    A few holders have their noses out of joint over the lack of feedback and publicity over Oraline 8 and Medica.

    I sympathise with this a lot. But I also like to be realistic. I have long accepted that publicity and investor relations is not a strong suit for this management. It ever has been and, while it has definitely improved (with quarterly updates and more expressive press releases/announcements), it is still falling well short of reasonable expectations. Particularly with respect to keeping the web site up to date and being more timely with announcements.

    But why throw out the baby with the bath water?

    In my view, the 'baby' - that is, the business plan and strategy - is going fine.

    As Aj has reminded us many times, just re-look at all the announcements/initiatives over the past 2 months. They are quite impressive!

    And there is more of this to come - with the 'real' O8 'launch' in January - as well as the Bioscreens launch, commencement of Chinese field testing, probably new distributorships from Medica leads and, hopefully, positive news from Mexico.

    It's business as usual for me. Just hoping there will be no further big shocks at the macro-scale so that SBN still has relatively in tact markets to do its business in.
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.